WorldPingEnhertu, which can give patients an extra seven months to live on average, has been prescribed in Scotland for more than two years and is available.
Outbreaks, approvals and guidance changes have direct practical consequences for care, travel and public-health planning.
When each newsroom published on this story, oldest first — all times UTC.
New hope for breast cancer patients as life-extending drug now on NHS in England
STAT+: England to cover AstraZeneca breast cancer drug, a result of U.K.-U.S. drug pricing deal
The original report was published by BBC Health. WorldPing does not claim that reporting — this page summarises and contextualises it.
Read the full report at BBC Health
WorldPingA breast cancer drug from AstraZeneca will now be available in England after a pricing deal was reached, in part a result of the U.S.-U.K. pharma pact.
Brief by WorldPing · Original reporting by STAT
WorldPingRolling coverage of the latest economic and financial news Bank of England urged to slow or halt bond-selling to slash UK borrowing costs The Guardian view on the Bank of England’s £120bn bill: power without accountability Newsflash: Britain’s econom…
Brief by WorldPing · Original reporting by The Guardian
WorldPingThe Bank of England is expected to keep interest rates unchanged, despite rising inflation in the UK…
Brief by WorldPing · Original reporting by ABC News
WorldPingForecasts of further rises in the inflation rate mean some analysts expect the Bank to act by the end of the year.
Brief by WorldPing · Original reporting by BBC Business
The Bank of England is expected to keep rates steady Thursday, even after U.K. inflation rose to 3.1% and energy costs keep pressure on prices.
Brief by WorldPing · Original reporting by CNBC World
Scientists are testing a counterintuitive way to fight mesothelioma, an aggressive asbestos-linked cancer with few effective treatments.
Brief by WorldPing · Original reporting by ScienceDaily
WorldPing